Operation Warp Speed Vaxart
South san francisco calif june 26 2020 globe newswire vaxart inc a clinical stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection today announced that its oral covid 19 vaccine has been selected to participate in a non human primate nhp challenge study organized and funded by operation warp speed a new national program aiming to provide substantial quantities of safe effective vaccine for americans by january 2021.
Operation warp speed vaxart. Among the trump administrations responses to covid 19 has been operation warp speed which commits the federal government to funding and coordinating development of vaccines drugs and. The study is designed to demonstrate the efficacy of vaxarts oral covid 19 vaccine candidate. In late june the stock got another boost when vaxart announced vxa cov2 1 had been selected for the governments operation warp speed program. Vaxarts vaccine an oral tablet was only.
On june 24 two days before the announcement the. Vaxart has not been chosen by operation warp speed to receive research funding but instead had limited involvement hhs told the new york times in july. Governments flagship effort to develop cures and treatments for covid 19. We are very pleased to be one of the few companies selected by operation warp speed and that ours is.
According to the department of health and human services hhs which sponsors the program operation warp speed aims to deliver 300 million doses of a safe effective vaccine for covid 19 by.